Clinical Trial Update: Role of Roflumilast in Ulcerative Colitis [Phase 4]

View source ↗

Summary

Phase 4 study investigating roflumilast for ulcerative colitis has completed. It represents a late-stage evaluation of this PDE4 inhibitor in inflammatory bowel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: Tanta University | Conditions: Ulcerative Colitis | Phase 4 | Status: COMPLETED